Atlas Venture Fund XII, L.P.
Insider CIK 1812049 · AVTE 10% owner · VIGL 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-07 | 4,808,896 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | D To issuer | 2025-08-05 | 2025-08-07 | 1,027,978 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | J Other | 2022-07-15 | 2022-07-19 | 310,388 | — | $0 | 2,327,909 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | J Other | 2022-04-01 | 2022-04-04 | 465,582 | — | $0 | 2,638,297 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 2,850,789 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion deriv | 2022-01-11 | 2022-01-11 | 7,852,374 | — | $0 | 0 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 1,027,978 | — | $0 | 1,027,978 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | P Buy | 2022-01-11 | 2022-01-11 | 535,000 | $14.00 | $7.49M | 4,808,896 | SEC↗ |
| VIGL Vigil Neuroscience, Inc. | C Conversion | 2022-01-11 | 2022-01-11 | 2,831,520 | — | $0 | 4,273,896 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion deriv | 2021-07-02 | 2021-07-06 | 7,976,754 | — | $0 | 0 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | C Conversion | 2021-07-02 | 2021-07-06 | 2,568,165 | — | $0 | 2,568,165 | SEC↗ |
| AVTE Aerovate Therapeutics, Inc | P Buy | 2021-07-02 | 2021-07-06 | 535,714 | $14.00 | $7.50M | 3,103,879 | SEC↗ |